2016 annual financial data

Alnylam Pharmaceuticals 2016 Financial results

Direct answer

Revenue was 47.16M USD.

Operating income was -424.59M USD and net income was -410.11M USD.
Operating cash flow was -307.7M USD.

Get free Alnylam Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
47.16M USD
Operating income
-424.59M USD
Net income
-410.11M USD
Operating cash flow
-307.7M USD